Wednesday, April 23, 2014

Breathe for Jo Campaign Fund Reaches £20,000 but More Help …

Generous well-wishers have responded to an urgent fundraising campaign for a mum suffering from two terminal illnesses – with an astonishing £20,000 pledged in less than two weeksThe Breathe for Jo campaign launched on April 10, to raise £30,000 in 30 days to send former Exeter College student More …

Wednesday, April 23, 2014

Fate Therapeutics Announces FDA Clearance of IND Amendment for …

Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug Application (IND) amendment to evaluate PROHEMA® in pediatric patients undergoing hematopoietic stem cell (HSC) transplantation for the treatment of hematologic malignancies. The FDA's clearance of the IND amendment allows the Company to expand its clinical investigation of PROHEMA®, which to date has only been administered t … More …

Wednesday, April 23, 2014

Scientists Pinpoint Protein That Could Improve Small Cell Lung …

Approximately 15 percent of all lung cancers are small cell lung cancers (SCLC), which grow rapidly and often develop resistance to chemotherapy. However, researchers at Virginia Commonwealth University Massey Cancer Center have revealed new insights into the mechanisms leading to this resistance that may lead to improved therapies. More …